Mohan Santhanam Thiruvazhi

Title: Mohan Santhanam Thiruvazhi: Innovator in Pharmaceutical Chemistry

Introduction

Mohan Santhanam Thiruvazhi is a notable inventor based in San Diego, CA. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target specific cancer pathways. With a total of 3 patents, his work has the potential to impact the treatment of proliferative diseases.

Latest Patents

Thiruvazhi's latest patents include innovative compounds aimed at inhibiting key cancer-related proteins. One of his notable inventions is titled "Substituted pyridazines as EGFR and/or KRAS inhibitors." This invention focuses on pyridazinone compounds and furan compounds, which are designed to treat proliferative diseases by administering therapeutically effective amounts of these compounds. The compounds were identified through extensive screening of small molecule libraries. Another significant patent is for "Tyrosine kinase inhibitors," which provides compounds that modulate tyrosine kinase activity, along with compositions and methods for their use.

Career Highlights

Throughout his career, Thiruvazhi has worked with reputable organizations such as Chembridge Corporation and the Sloan-Kettering Institute for Cancer Research. His experience in these institutions has allowed him to refine his expertise in drug development and molecular design.

Collaborations

Thiruvazhi has collaborated with several professionals in his field, including Alexander Chucholowski and Vlad Edward Gregor. These collaborations have contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Mohan Santhanam Thiruvazhi is a distinguished inventor whose work in pharmaceutical chemistry has led to the development of innovative compounds for cancer treatment. His contributions are paving the way for new therapeutic options in the fight against proliferative diseases.